3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
11
Stomach Neoplasms
10
Carcinoma, Non-Small-Cell Lung
5
Rectal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Recurrence
2
Nasopharyngeal Carcinoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Turcot syndrome
1
Thyroid Neoplasms
1
Squamous Non-Small Cell Lung Cancer SqNSCLC
1
Spinocerebellar Degenerations
1
Small Cell Lung Carcinoma
1
Resectable Non-small Cell Lung Cancer
1
Rare Tumour
1
Pancreatic Neoplasms
1
Pancreatic Cancer Resectable
1
Pancreatic Cancer Metastatic
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Locally Advanced Non-Small Cell Lung Cancer
1
Liver Neoplasms
1
Hodgkin Disease
1
HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
1
Esophageal Neoplasms
1
Interventions
Immune Checkpoint Inhibitors
2
sintilimab
1
Oxaliplatin
1
Capecitabine
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Spinocerebellar Degenerations
×
sintilimab
×
Clear all
NCT06594692
2024-09-19
mRCAT-C
Sir Run Run Shaw Hospital
Phase 2
Not yet recruiting
140 enrolled